David M. Remick

Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine

David M. Bender, Jingqi Bao, Anne H. Dantzig et al. · Journal of Medicinal Chemistry · 2009 · 107 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +14

Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1<i>S</i>,3<i>R</i>)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

Junliang Hao, James P. Beck, John M. Schaus et al. · Journal of Medicinal Chemistry · 2019 · 56 citations · Full text

Pharmacological Characterization, Drug Target, Pharmacotherapy +21

Novel Method for the Determination of Piperazine in Pharmaceutical Drug Substances Using Hydrophilic Interaction Chromatography and Evaporative Light Scattering Detection

Carlie McClintic, David M. Remick, Jeffrey A. Peterson et al. · Journal of Liquid Chromatography & Related Technologies · 2003 · 39 citations

Engineering, Organic Chemistry, Chemistry +17

An Investigation into the Influence of Counterion on the Properties of Some Amorphous Organic Salts

Christopher Towler, Tonglei Li, Håkan Wikström et al. · Molecular Pharmaceutics · 2008 · 35 citations

Engineering, Organic Chemistry, Chemistry +18

Isolation and Physical Property Optimization of an Amorphous Drug Substance Utilizing a High Surface Area Magnesium Aluminometasilicate (Neusilin ® US2)

Matthew Allgeier, Jared L. Piper, Jeremy Hinds et al. · Journal of Pharmaceutical Sciences · 2016 · 14 citations

Materials Engineering, Materials Science, Physical Property Optimization +9